HOME / PUBLICATIONS /

Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non–small cell lung cancer

Citation:

Dahabreh IJ, Linardou H, Siannis F, Kosmidis P, Bafaloukos D, Murray S. Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non–small cell lung cancer. Clinical Cancer Research. 2010;16:291–303. Copy at http://www.tinyurl.com/yte7qbvr